GlassScriptPhysician profile
Constance B Campbell
NPI 1306250923
$1,819.41
in general payments reported to CMS, 2019-2025
18 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.28 · 2020: $122 · 2021: $464 · 2022: $418 · 2023: $334 · 2024: $168 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $502.89 | 2022-2024 | Lumigan, Vuity, Alphagan P |
| Kala Pharmaceuticals, INC. | $258.29 | 2021 | |
| Alcon Vision LLC | $242.55 | 2020-2025 | Total30, Precision 1 |
| Allergan, INC. | $200.69 | 2019-2022 | |
| Sight Sciences, INC. | $149.86 | 2025 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $135.72 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $48.69 | 2020-2021 | |
| Coopervision INC. | $39.38 | 2025 | Myday Contact Lens |
| Eyevance Pharmaceuticals LLC | $38.43 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $36.93 | 2024-2025 | |
| Dompe US, INC. | $25.54 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $22.31 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $21.97 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $21.89 | 2022 | |
| Glaukos Corporation | $21.26 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $19.62 | 2022 | |
| Bausch & Lomb Americas INC. | $18.22 | 2022 | |
| Biotissue Holdings INC. | $15.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.